EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SLC12A8 Drives Immune Evasion and Metastasis in Luminal B Breast Cancer by Inducing CD8 + T‐Cell Exhaustion via the TLR Signaling Pathway

Zhiyong Liu iD, Ran Chen

Cancer Medicine · 2026

DOI: 10.1002/cam4.71712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Zhiyong Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Breast Treatment Center, the First Affiliated Hospital of Gannan Medical University, Ganzhou, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Breast Neoplasms, Solute Carrier Family 12, Tumor Escape. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gannan Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the role and mechanism of SLC12A8 in the progression of Luminal B breast cancer.

Methods

Data from TCGA, GTEx, and HPA databases were used to analyze SLC12A8 expression and its prognostic value in breast cancer. qPCR was performed to validate SLC12A8 expression in various breast cancer cell lines. The correlation between SLC12A8 and immune cell infiltration was analyzed using ImmuCellAI and TIMER databases. Gene set enrichment analysis (GSEA) was employed to predict signaling pathways associated with SLC12A8. In vitro, siRNA‐mediated knockdown of SLC12A8 or treatment with the TLR pathway inhibitor GIT27 was used to assess the effects on the TLR pathway, CD8 + T cell function (as indicated by PD‐1, PRF1, and GZMB expression), and cancer cell invasion via Western blot, immunofluorescence, qPCR, and Transwell assays. CD8 + T cells were isolated from healthy human peripheral blood using magnetic bead separation (Miltenyi Biotec, CD8 MicroBeads) and activated with anti‐CD3/CD28 beads prior to co‐culture. Additional functional assays included IFN‐γ/IL‐2 ELISA and cytotoxicity assays.

Results

SLC12A8 was significantly upregulated in breast cancer tissues and cell lines, and its high expression correlated with poor patient prognosis. Bioinformatic analysis and experimental validation confirmed that high SLC12A8 expression was strongly associated with reduced infiltration and functional inhibition of CD8 + T cells in the tumor microenvironment, particularly in Luminal B breast cancer. Mechanistically, SLC12A8 activated the TLR signaling pathway (upregulating TLR2, MyD88, IRAK1, TAK1 in CD8 + T cells), leading to increased PD‐1 expression on CD8 + T cells, resulting in their functional exhaustion and enhanced invasive ability of Luminal B breast cancer cells. Knockdown of SLC12A8 or TLR pathway inhibition reversed these effects. Overexpression of SLC12A8 in normal breast epithelial cells recapitulated the exhausted T‐cell phenotype, and TLR2 agonist treatment mimicked SLC12A8 effects.

Conclusion

SLC12A8 promotes immune evasion and metastasis in Luminal B breast cancer by inducing CD8 + T‐cell exhaustion via activation of the TLR signaling pathway, suggesting its potential as a prognostic biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesBreast NeoplasmsSolute Carrier Family 12Tumor EscapeToll-Like ReceptorsHumansFemaleSignal TransductionT-Cell ExhaustionCell Line, TumorGene Expression Regulation, NeoplasticPrognosisTumor MicroenvironmentNeoplasm Metastasis

Stichwörter der Autor:innen

CD8+ T‐cell exhaustionImmune evasionLuminal B breast cancerSLC12A8Toll‐like receptor signaling pathway

Substanzen

Solute Carrier Family 12Toll-Like Receptors

Autor:innen und Institutionen

  • Breast Treatment Center, the First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

ORCID-Profile: Zhiyong Liu

Förderung

  • Gannan Medical University

Zitieren

APA

Liu, Z., & Chen, R. (2026). SLC12A8 Drives Immune Evasion and Metastasis in Luminal B Breast Cancer by Inducing CD8 + T‐Cell Exhaustion via the TLR Signaling Pathway. Cancer Medicine. https://doi.org/10.1002/cam4.71712

Vancouver

Liu Z, Chen R. SLC12A8 Drives Immune Evasion and Metastasis in Luminal B Breast Cancer by Inducing CD8 + T‐Cell Exhaustion via the TLR Signaling Pathway. Cancer Medicine. 2026. doi:10.1002/cam4.71712

BibTeX
@article{Liu2026,
  author = {Liu, Zhiyong and Chen, Ran},
  title = {SLC12A8 Drives Immune Evasion and Metastasis in Luminal B Breast Cancer by Inducing CD8 + T‐Cell Exhaustion via the TLR Signaling Pathway},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71712}
}
Kostenlos starten →